Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML

Clinical trial NCT00583102 · TERMINATED

Trial details

NCT number: NCT00583102
Sponsor: University of Iowa
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2001-06-01
Primary completion: 2013-02-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.